In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Papers and articles

A selection of articles and papers published either by the Working Group or its members

Venous Thromboembolism

Euro Heart Journal Publications

ESC Guidelines

  • 2004 - Expert Consensus Document on the Use of Antiplatelet Agents
    The Task Force on the Use of Antiplatelet Agents in Patients with Atherosclerotic Cardiovascular Disease of the European Society of Cardiology: Carlo Patrono (Chairperson), Fedor Bachmann, Colin Baigent, Christopher Bode, Raffaele De Caterina, Bernard Charbonnier, Desmond Fitzgerald, Jack Hirsh, Steen Husted, Jan Kvasnicka, Gilles Montalescot, Luis Alberto Garcı´a Rodrı´guez, Freek Verheugt, Jozef Vermylen, Lars Wallentin
    EHJ 2004;25:166-181

Articles published in the E-Journal of Cardiology Practice

Volume 5

  • Cardiovascular Disease Prevention / Risk Assessment and Management - Anti-thrombotic therapy : news from ESC Congress 2006 / World Congress of Cardiology 2006 (Read more)

Volume 4

  • Clinical pharmacology - Oral anti-platelet therapy and coronary stenting (Read more)

Volume 3

  • Acute Coronary Syndromes (ACS) - ST-elevation myocardial infarction – should choice of reperfusion therapy depend on the duration of symptoms? (Read more)
  • Chronic Ischaemic Heart Disease (IHD) - n-3 fatty acids in the secondary prevention of coronary heart disease (Read more)
  • Acute Coronary Syndromes (ACS) - The immediate anti-thrombotic therapy in patients with acute coronary syndromes. (Read more)

Volume 2

  • Thromboembolic Venous Disease - Low molecular weight heparin against venous thromboembolism in patients with cancer (Read more)
  • Thromboembolic Venous Disease - Extended prevention of venous thromboembolism following an initial six month period of warfarin therapy. (Read more)

Volume 1

  • Alteplase and pulmonary embolism (Read more)
  • Acute Coronary Syndromes (ACS) - Tailored anti-thrombotic therapy in acute coronary syndromes. (Read more)
  • Thromboembolic Venous Disease - Intensity and duration of oral anti-coagulation therapy in venous thrombo-embolism (Read more)
  • Warfarin is superior to aspirin after acute myocardial infarction. (Read more)